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ABSTRACT
Objective: The objective of this study is to evaluate the functioning and status of implementation of hemovigilance program of India (HvPI) in the 
blood banks of southern Kerala.
Methods: It was a survey approach to analyze the facilities, working nature, and status of implementation of hemovigilance program by the blood 
banks located in the three districts of southern Kerala. Both goevrnment and private sector blood banks were subjected to the survey. Standard pro 
forma was used to collect the data. Collected data were analyzed by percentages and ratios.
Results: A total of 40 blood banks were covered in the study. All the blood banks were licensed for handling whole blood. 23 blood banks were licensed 
for handling blood components. 6 blood banks process 100% blood into components. Majority of blood banks have excellent demand for components. 
Packed red cells, platelet concentrate, and fresh frozen plasma were the significant components among the prepared components. Majority of the 
blood banks under the survey had hospital transfusion committee (HTC). 25 blood banks replied as the HvPI is an excellent/good system. However, 
only 11 blood banks were enrolled in the HvPI. Training programs for the resident doctors and nurses regarding with adverse transfusion reaction 
and their reporting were not conducted by 17 blood banks.
Conclusion: Except very few blood banks, all are need more awareness and training programs. Attention should be given in the area such as 
underreporting, poor implementation of hemovigilance, only serious reactions reporting, and avoiding minor reactions. Core factor is proper 
functioning of HTC and awareness programs about hemovigilance system.
Keywords: Functioning, Hemovigilance program of India implementation, Blood banks.
INTRODUCTION
Transfusion of blood and blood components is one of the important 
aspects of modern therapeutics [1-3]. Collection and issue of blood and 
its components are the general responsibilities of blood banks. However, 
nowadays, they have some additional challenges and responsibilities, 
importantly, hemovigilance measures have to be organized, hospital 
transfusion committees (HTCs) are desirable, and quality systems are 
needed [4].
Initially, awareness on blood safety was developed at the end of 1980s due 
to the transmission of infection by transfusion that leads to organizing 
the hemovigilance system in 1991 at France with the arrangement of 
monitoring systems by transfusion committees, resulting in a national 
hemovigilance network in 1994 [5]. The hemovigilance is defined as 
a set of surveillance procedures covering the whole transfusion chain 
from the collection of blood and its components up to the follow-up 
of its recipients intended to collect and assess information on adverse 
effects, resulting from the use of blood products and to prevent their 
occurrence or recurrence. Hemovigilance program of India (HvPI) was 
launched on 10th December 2012. It is a centralized, well-structured 
program for monitoring adverse reactions associated with transfusion 
of blood and administration of blood products [6-9].
The vein-to-vein concept is the key factor in transfusion medicine. 
It covers the entire transfusion chain, that stretching from donor to 
recipient, and also covers the production as well as usage segment. 
Due to this multistep involvement of staffs of different departments, it 
is of prime importance to ensure the quality and safety of transfusion 
in the hospital. To comply with these standard requirements, the 
hospitals must develop proper strategies. However, in India, the 
blood usage system is different compared with other developed 
countries. The need of HTC was come into focus in 2002 when 
national blood policy was established. One of the main objectives of 
the National Blood Policy is “to encourage appropriate clinical use 
of blood and its products.” It was suggested that every institution 
having a blood transfusion department should comprise HTC and its 
role was detailed [5].
According to the World Health Organization, “A transfusion committee 
should be establishing in each hospital to implement the national 
policy and guidelines and monitor the use of blood and blood products 
at the local level.” Obviously, the HTC plays an important role in 
promoting safety, efficacy, and efficiency of transfusion services. It is 
a multidisciplinary team and involves all departments in the hospital 
that are involved in providing and prescribing blood and blood 
products. The members of HTC include medical superintendent of 
hospital as the chairperson, representatives from medicine, surgery, 
obstetrics, gynecology, orthopedics, and nursing superintendent as 
members. The convener of the committee is the head from transfusion 
medicine department. The HTC sets appropriate policies and 
procedures, reviews and revise them, and monitors practice against 
them [5,10-12].
In the present study, it was decided to evaluate the functioning and 
status of implementation of HvPI in the blood banks of southern Kerala, 
an attempt to provide a direction for further research.
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METHODS
In the present study, a survey was done to analyze the facilities, working 
nature, and status of implementation of hemovigilance program by the 
blood banks located in the three districts of southern Kerala, namely, 
Thiruvananthapuram, Kollam, and Pathanamthitta. A total of 40 blood 
banks were covered in the study. A standard pro forma prepared with 
the guidance of an expert team of doctors in the field of transfusion 
medicine was used to collect the data which is presented in Table 1. 
Collected data were analyzed by percentages and ratios.
RESULTS AND DISCUSSIONS
A total of 40 blood banks of both public and private sectors were 
covered during the study period which is presented in Table 2.
Analysis of blood products handled by these blood banks revealed that 
all the blood banks under the study were licensed for handling the 
whole blood. 23 of 40 blood banks were licensed for handling blood 
components which include 5 blood banks possess the apheresis facility 
also. The results of analysis of the percentage of blood processed in to 
components by subject blood banks were shown in Table 3 and Fig. 1. 
It was found that only six blood banks (26.08%) process 100% blood 
into components. This study suggests that the clinicians are to be made 
aware about the advantages of components and optimal blood use as 
the blood is scares. This can be ensured by the proper implementation 
of hemovigilance program.
The responses of blood banks regarding with demand of components in 
own clinical facility are shown in Table 4 and Fig. 2.
The response of blood banks regarding with demand of components 
is excellent/good in the case of 33 blood banks (82.5%), of which 23 
blood banks have the components facility. Fair demand is expressed 
by 4 (10%) blood banks, of which 2 blood banks have no component 
facilities. The poor demand of components for the clinical facility is 
expressed by 3 (7.5%) blood banks, and 7 blood banks have the need 
for whole blood only.
Types of blood components prepared by blood banks under the study 
are shown in Table 5 and Fig. 3. Ideally, processing of blood into its 
components is more advantageous to patients because they receive 
only their exact need. Moreover, the adverse reaction rate can be 
reduced by issuing components. Creating the awareness about the 
advantages of components among the clinicians may increase the 
demand of components. HTC must be effective. Only the active HTC can 
report and follow-up the actions properly. Importantly, clinicians are 
to be trained and made aware about the importance of hemovigilance 
program. However, there is also a chance of misinformation from the 
side of participants.
Majority of the study subjects (92.5%) have HTC. It is evident that HTC 
is not constituted in 3 blood banks. 95% of blood banks reports that 
adverse transfusion reactions are not reported to the blood bank from 
Table 1: Pro forma used for the collection of data
Question Response
Whether blood bank is licensed for Whole blood/components/apheresis
What percentage of blood is processed in to components
What is the demand of your component by your clinical facility Excellent/good/fair/poor
Which components are being prepared in your blood bank Whole blood/packed red cells/washed red cells/leukodepleted red 
cells/irradiated red cells/single donor platelets/platelet concentrate/
platelet-rich plasma/fresh frozen plasma/cryoprecipitate/cryo-poor 
plasma 
Do you have HTC Yes/no
Does adverse transfusion reaction are reported to the blood 
bank from the clinical wards
Yes/no
Do you know about the HvPI Yes/no
Have your blood bank enrolled in the HvPI Yes/no
If yes, do you report regularly Yes/no
If no, what is the reason for not enrolling Not aware/fear of any punitive action/procedure not known/no system 
for adverse reaction reporting in the hospital/not interested
Are you planning to enroll yourself to HvPI Yes/no




What are your views on reporting adverse donor reactions Yes/no
Are you maintaining documents of adverse donor 
reactions (In-house/Camps)
Yes/no
Do you have SOP manual on investigation and management of 
adverse donor reactions
Yes/no
Do you have SOP manual on investigation and management of 
adverse transfusion reaction
Yes/no
If yes, do you discuss the reports of adverse transfusion 
reactions in the HTC
Yes/no
Have you conducted any training program for the resident 
doctors and nurses for adverse transfusion reaction and their 
reporting
Yes/no
Your view points on the overall HvPI Excellent/good/fair/poor
HvPI should be Voluntary reporting/mandatory reporting
Regular National CME should be done for the program Yes/no
Program should be non-punitive Yes/no
Program should have uniform pattern of reporting of reaction Yes/no
Program should not have any legal issues Yes/no
Program should not have any conflict of interest Yes/no
Name and address of blood bank
HTC: Hospital transfusion committee, CME: Continuing medical education, SOP: Standard operating procedure, HvPI: Hemovigilance program of India
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the clinical wards. This indicates that HTC is not functioning properly 
even though it is formed. If there is any underreporting or reporting 
of serious reactions only, it reflects the poor implementation of 
hemovigilance. In every country, it is mandatory that HTC is to ensure 
reporting of transfusion reactions.
In the present study, it was found that 17% of the blood banks still do 
not have the knowledge on HvPI. This indicates the need for awareness 
programs. The next three questions regarding with HvPI received a 
mixed responses from the participants. The questions and the replies 
of participants are shown in Fig. 4 and Table 6.
Only 11 blood banks (27.5%) were enrolled in the HvPI. Of this, 3 blood 
banks were not reporting properly. Moreover, 20 blood banks were not 
familiar to the procedure for enrollment, and one expressed that it was 
due to the fear of punitive action. One blood bank did not enroll in the 
program due to the unavailability of system for the reporting of adverse 
reaction in the hospital. 4 blood banks (10%) were not planning to 
Table 2: Distribution of blood banks selected for the study
Private Medical College 
blood banks
Government Medical College blood banks Other Government Hospital 
blood banks
Institutes Corporate Total
9 2 5 2 22 40
Table 3: Percentage of blood processed into components by 















Table 4: Response of blood banks regarding with demand of 
components in own clinical facility
Response of blood banks regarding with 








Table 5: Types of blood components prepared by blood banks 
under the study






Packed red cells 23 100
Washed red cells 5 21.74
Leukodepleted red cells 5 21.74
Irradiated red cells 1 04.35
Single donor platelets 8 34.78
Platelet concentrate 23 100
Platelet-rich plasma 14 60.87
Fresh frozen plasma/ 23 100
Cryoprecipitate 15 65.22
Fig. 1: Percentage of blood processed in to components by blood 
banks under the study
Fig. 2: Response of blood banks regarding with demand of 
components in own clinical facility
enroll in this program that indicates the need of more awareness and 
training program in this regard.
The question “what are your views on reporting of adverse transfusion 
reaction” was received a different type of replies from participating blood 
banks which are presented in Table 7 and Fig. 5. The results showed 
that documents of adverse transfusion and donor reactions, standard 
operating procedures (SOP) manual for investigation, and management 
of adverse transfusion and donor reactions were not maintained by 
some of the blood banks. Training programs for the resident doctors and 
nurses regarding with adverse transfusion reaction and their reporting 
were not conducted by 17 blood banks (42.5%), which indicates that 
more awareness programs and training are needed in this regard.
Various initiatives such as time management in reporting to blood 
bank, complete investigation for identifying the preventive measures, 
SOP preparation, and training programs should discuss in the HTC. 
Such initiatives may helpful to identify and prevent adverse transfusion 
reactions and make blood transfusion safer. Importantly, reporting 
should be prompt and adverse reactions need to be investigated.
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With the help of these steps,
•	 Quality	of	patients	transfusion	care	can	be	improved.	At	the	same	




Regarding with adverse donor reaction reporting system, it is an 
excellent initiative to identify and prevent adverse donor reactions 
and make blood donation safer and pleasant. Adverse donor reaction 
reporting throws light to the different unreported causes of donor 
reactions. It should be mandatory and must report because the satisfied 
donors have a major role in transfusion. Attention in the area such as 
donor education, motivation, recruiting of voluntary donors, creating 
pleasant and friendly atmosphere, management of donor reactions 
according to SOP, social workers, transfusion committee, and media 
may give better improvements.
Diverse views of blood banks were collected regarding with the HvPI. 
From the views of blood banks, generally, it can be concluded that HvPI 
Table 6: Responses of participants regarding with HvPI
Question Response received Number of blood banks (%)
Have your blood bank enrolled in HvPI Yes 11 (27.5)
No 29 (72.5)
If “yes” do you report regularly to HvPI Yes 8 (20)
No 32 (80)
If “no” what is the reason for not enrolling to HvPI Not aware 8 (20)
Procedure not known 21 (52.5)
Fear of any punitive action 1 (2.5)
No system of adverse reaction reporting in the hospital 1 (2.5)
Not interested Nil (0)
Are you planning to enroll yourself to HvPI Yes 36 (90)
No 4 (10)
HvPI: Hemovigilance Program of India
Table 7: Questions and replies of blood banks regarding with adverse transfusion reaction
Questions Replies Number of blood banks (%)








Do you have a SOP manual on investigation and management of adverse 
transfusion reaction?
Yes All blood banks (100)
No Nil (0)




Have you conducted any training program for the resident doctors and 
nurses for adverse transfusion reaction and their reporting?
Yes 23 (57.5)
No 17 (42.5)
SOP: Standard operating procedure, HTC: Hospital transfusion committee
Table 8: Questions and replies of blood banks regarding with HvPI
Questions Replies Number of blood banks (%)




HvPI should be Voluntary reporting 21 (52.5)
Mandatory reporting 19 (47.5)
Regular National CME should be done for the program Yes 36 (90)
No 4 (10)
Program should be non-punitive Yes 35 (87.5)
No 5 (12.5)
Program should have uniform pattern of reporting of reaction Yes 39 (97.5)
No 1 (2.5)
Program should not have any legal issues Yes 35 (87.5)
No 5 (12.5)
Program should not have any conflict of interest Yes 38 (95)
No 2 (5)
HvPI: Hemovigilance Program of India
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is an excellent initiative to identify and prevent adverse transfusion 
reactions and donor reactions and make blood transfusion safer. The 
reports collected from the blood banks are presented in Table 8. It 
showed that 62% of the blood banks have expressed that the HvPI is 
excellent/good. 52.5% of the blood banks have the opinion that the 
reporting should be voluntary and almost equally. 47.5% expressed 
that the program should be mandatory. Majority of the blood banks 
expressed that the program should have a uniform pattern of 
reporting of reaction and should not have any legal issues and conflict 
of interest. However, only 11 of 40 (27.5%) study subjects were 
enrolled with HvPI and only 8 among them properly reports to the 
hemovigilance system.
Ultimately, the challenge for improving the safety of transfusion chain 
rests primarily in designing and implementing systems that enhance 
the oversight of transfusion practices and seek to optimize patient 
safety and efficient utilization of a scarce resource [9]. The results 
of the present study showed that majority of the blood banks have 
a better demand for the blood components. Various types of blood 
components such as packed red cells, washed red cells, leukodepleted 
red cells, irradiated red cells, single donor platelets, platelet 
concentrate, platelet-rich plasma, fresh frozen plasma, cryoprecipitate, 
and fresh/liquid plasma (cryo-poor plasma) are available in these 
blood banks. However, the availability of products differed among the 
blood banks. Except 3 of 40 study subjects, all are having HTC but not 
properly reported the adverse transfusion reactions to the blood bank 
from the clinical wards. However, only 11 of 40 study subjects were 
enrolled with HvPI and only 8 among them properly reported to the 
hemovigilance system. However, most of them accepted that it is a 
valuable system even they have different opinions about the various 
aspects of this program.
CONCLUSION
The present study indicated various import steps requiring immediate 
attention. They are as follows
•	 Local	policies	and	guidelines	should	develop	at	the	institutional	level	
based on national guidelines.
•	 Different	 aspects	 of	 transfusion	 chain	 such	 as	 indications,	
contraindications, transfusion triggers, dosage, technical aspects, 
blood alternatives, and documentation should becovered. Safety 
aspects	of	blood	transfusion	such	as	identification	of	patient	samples,	
bedside checks, post-transfusion follow-up, and measures in case of 
an adverse reaction should also be included.
•	 Education	 to	 the	end	users	may	 fill	 the	gap	 in	medical	education	
pertaining to transfusion medicine. Interactive training programs, 
printed	education	materials	 are	beneficial	one	 in	 this	 regard.	 In	
such sessions, a pre- and post-training assessment of participants 
pertaining to their knowledge related to safe transfusion practice 
may useful.
•	 Encouraging	the	staff	to	report	each	and	every	adverse	event	related	
to transfusion is essential one.
•	 Prime	 importance	 should	be	 given	 to	 join	with	hemovigilance	
program of India. The program should be mandatory, then only all 
the blood banks would be enrolled with the program.
•		 Implementation	of	newer	technology	like	leukoreduction	to	reduce	
the FNHTR, irradiation in the case of transplantation is the results of 
proper hemovigilance system. It should be non-punitive, and blood 
banks should be convinced that the data are used only for assessment 
and improvement of transfusion practices.
•	 HTC	should	ensure	mandatory	reporting	of	transfusion	reactions.	
Attention should be given in the area such as underreporting, poor 
implementation of hemovigilance, only serious reactions reporting, 
and avoiding minor reactions.
•	 Core	factor	is	proper	functioning	of	HTC	and	awareness	programs	
about hemovigilance system.
Fig. 4: Responses of participants regarding with hemovigilance 
program of India
Fig. 5: Questions and replies of blood banks regarding with 
adverse transfusion reaction
Fig. 3: Types of blood components prepared by blood banks 
under the study
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